ATEX Stock Analysis: Anterix | NASDAQ
Telecom Services | NASDAQ, USA | Market Cap: 1.469m USD | 12M Return: 346.7% | US03676C1009 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.8M
Qual. Beats: 0
Rev. Trend: 88.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Anterix Inc. (NASDAQ: ATEX) is a communication services company that holds licensed 900 MHz spectrum used to serve utility and critical infrastructure enterprise customers across the contiguous United States, Hawaii, Alaska, and Puerto Rico. Its offerings include TowerX for tower site access, CatalyX for turnkey connectivity management, and the Anterix Active Ecosystem. The company, formerly known as pdvWireless, Inc. until its August 2019 rebrand, was incorporated in 1997 and is headquartered in Woodland Park, New Jersey.
Anterix operates in the wireless telecommunication services sub-industry and focuses on private LTE networks rather than consumer mobile services. The 900 MHz band is a low-frequency spectrum widely valued for its long-range propagation and strong building-penetration characteristics, making it well suited for wide-area utility and industrial communications. The company has positioned itself as a key enabler of private broadband networks for utilities modernizing their grid infrastructure.
- Utility private LTE contracts drive recurring spectrum lease revenue
- FCC 900 MHz band reallocation expands addressable utility market
- Spectrum sale proceeds accelerate network deployment and customer growth
| Net Income: 65.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 13.95 > 1.0 |
| NWC/Revenue: 1.73k% < 20% (prev 327.7%; Δ 1.40k% < -1%) |
| CFO/TA 0.02 > 3% & CFO 10.7m > Net Income 65.7m |
| Net Debt (-111.9m) to EBITDA (1.96m): -56.99 < 3 |
| Current Ratio: 4.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (19.6m) vs 12m ago 4.94% < -2% |
| Gross Margin: 93.41% > 18% (prev 100.0%; Δ -6.59% > 0.5%) |
| Asset Turnover: 1.64% > 50% (prev 1.65%; Δ -0.01% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.24 (Total Current Assets 153.1m - Total Current Liabilities 31.5m) / Total Assets 497.9m |
| B: -0.61 (Retained Earnings -302.1m / Total Assets 497.9m) |
| C: 0.00 (EBIT TTM 1.52m / Avg Total Assets 428.8m) |
| D: 1.35 (Book Value of Equity 285.8m / Total Liabilities 212.1m) |
| Altman-Z'' = 1.06 = BB |
| DSRI: 2.25 (Receivables 14.3m/5.33m, Revenue 7.04m/5.92m) |
| GMI: 1.07 (GM 100.0% / 93.41%) |
| AQI: 0.82 (AQ_t 0.68 / AQ_t-1 0.83) |
| SGI: 1.19 (Revenue 7.04m / 5.92m) |
| TATA: 0.11 (NI 65.7m - CFO 10.7m) / TA 497.9m) |
| Beneish M = -1.89 (Cap -4..+1) = B |
As of October 29, 2026, the stock is trading at USD 87.95 with a total of 219,679 shares traded. Over the past week, the price has changed by +14.56%, over one month by +7.58%, over three months by -3.74% and over the past year by +346.67%.
Current recommended Stop Loss: 81.60 (which is 7.2% or 1.2 ATR below the current price).
Anterix has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy ATEX.
- StrongBuy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 112.3 | 27.7% |
P/E Trailing = 21.4
P/S = 208.6029
P/B = 5.8453
Revenue TTM = 7.04m USD
EBIT TTM = 1.52m USD
EBITDA TTM = 1.96m USD
Long Term Debt = 2.64m USD (estimated: total debt 4.09m - short term 1.45m)
Short Term Debt = 1.45m USD (from shortTermDebt, last quarter)
Debt = 4.09m USD (from shortLongTermDebtTotal, last quarter) (leases 4.09m already included)
Net Debt = -111.9m USD (calculated: Debt 4.09m - CCE 116.0m)
Enterprise Value = 1.36b USD (1.47b + Debt 4.09m - CCE 116.0m)
Interest Coverage Ratio = unknown (Ebit TTM 1.52m / Interest Expense TTM 0.0)
EV/FCF = 92.97x (Enterprise Value 1.36b / FCF TTM 14.6m)
FCF Yield = 1.08% (FCF TTM 14.6m / Enterprise Value 1.36b)
FCF Margin = 207.3% (FCF TTM 14.6m / Revenue TTM 7.04m)
Net Margin = 933.0% (Net Income TTM 65.7m / Revenue TTM 7.04m)
Gross Margin = 93.41% ((Revenue TTM 7.04m - Cost of Revenue TTM 464k) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 2.73 (Enterprise Value 1.36b / Total Assets 497.9m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 4.09m)
Taxrate = 10.49% (7.70m / 73.4m)
NOPAT = 1.36m (EBIT 1.52m * (1 - 10.49%))
Current Ratio = 4.85 (Total Current Assets 153.1m / Total Current Liabilities 31.5m)
Debt / Equity = 0.01 (Debt 4.09m / totalStockholderEquity, last quarter 285.8m)
Debt / EBITDA = -56.99 (Net Debt -111.9m / EBITDA 1.96m)
Debt / FCF = -7.67 (Net Debt -111.9m / FCF TTM 14.6m)
Total Stockholder Equity = 256.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.32% (Net Income 65.7m / Total Assets 497.9m)
RoE = 25.65% (Net Income TTM 65.7m / Total Stockholder Equity 256.1m)
RoCE = 0.59% (EBIT 1.52m / Capital Employed (Equity 256.1m + L.T.Debt 2.64m))
RoIC = 0.29% (NOPAT 1.36m / Invested Capital 467.5m)
WACC = 10.06% (E(1.47b)/V(1.47b) * Re(10.09%) + D(4.09m)/V(1.47b) * Rd(0.0%) * (1-Tc(0.10)))
Discount Rate = 10.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 74.04 | Cagr: 2.71%
[DCF] Terminal Value 69.67% ; FCFF base≈14.6m ; Y1≈14.7m ; Y5≈15.5m
[DCF] Fair Price = 15.24 (EV 187.0m - Net Debt -111.9m = Equity 298.9m / Shares 19.6m; r=10.06% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.02 | # QB: 0
Revenue Correlation: 88.16 | Revenue CAGR: 30.07% | SUE: -0.10 | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.28 | Chg30d=-257.28% | Revisions=+0% | Analysts=3
EPS next Quarter (2026-12-31): EPS=-0.21 | Chg30d=-213.00% | Revisions=+0% | Analysts=3
EPS current Year (2027-03-31): EPS=-1.11 | Chg30d=+28.60% | Revisions=+0% | GrowthEPS=-123.1% | GrowthRev=+220.4%
EPS next Year (2028-03-31): EPS=-0.59 | Chg30d=-113.09% | Revisions=-25% | GrowthEPS=+47.0% | GrowthRev=-14.4%
[Analyst] Revisions Ratio: -25% (up=0, down=1)